Overall rank by patents
#40,379
of 49,997 tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 3 technology areas, recorded in grant years 2015–2016. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).
The verdict
According to USPTO PatentsView, GE ranks #40,379 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 3 technology areas.
USPTO PatentsView assignee plate
Corpus R40379 · US Corporation #40,379 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: GBS Global Biopharma, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
GE Healthcare… · this assignee
21 score
3D Lighting… · lowest
7 score
What this shows GE's Innovation Score is 20.9/100 (8th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
GE Healthcare Dharmacon, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2016 (5 grants) versus a trough of 1 in 2015. By volume, GE sits between GBS Global Biopharma, Inc. and Geann Industrial CO.,LTD..
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
GBS Global Biopharma, Inc.
6 patents
GCS German Capsule Solution GMBH
6 patents
Gcsol Tech Co., Ltd.
6 patents
GE Energy Power Coversion GMBH
6 patents
GE Phosphors Technology, LLC
6 patents
GE Vernova Renovables Espana, S.L.
6 patents
GEA Brewery Systems GmbH
6 patents
Geann Industrial CO.,LTD.
6 patents
GE Healthcare Dharmacon, Inc.
6 patents
What this shows GE holds 6 patents at rank #40,359, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #40,359 in granted patent volume.
Other assignees with the most granted patents in GE's primary technology class.
GE's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
21 8th percentile higher than 8% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 16.7% |
| 2016 | 5 | 83.3% |
Top 3 of 3 technology areas
Overall rank by patents
#40,379
of 49,997 tracked assignees
20.9 out of 100
What to do with this data
GE Healthcare Dharmacon, Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.